Home / Inspections / 1181891

FDA Inspection 1181891 — SmithKline Beecham Pharma GmbH & co. KG

SmithKline Beecham Pharma GmbH & co. KG — FEI 3004835618

The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on September 20, 2022 in Dresden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 20, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)

Facility

Other inspections at this facility

  • 1233707 (VAI Fri Mar 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1101506 (NAI Fri Jul 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019795 (VAI Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736162 (VAI Wed Jun 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 668686 (VAI Mon May 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources